SG Americas Securities LLC reduced its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

VaselineAugust 15, 2024

0 4 minutes read

SG Americas Securities LLC reduced its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 94.6% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 74,019 shares of the medical instruments supplier’s stock after selling 1,299,402 shares during the period. SG Americas Securities LLC’s holdings in DENTSPLY SIRONA were worth $1,844,000 at the end of the most recent reporting period.

A number of other hedge funds have recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of DENTSPLY SIRONA by 44.2% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock worth $4,684,000 after buying an additional 43,230 shares during the period. Seven Eight Capital LP acquired a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at $1,409,000. Illinois Municipal Retirement Fund raised its position in shares of DENTSPLY SIRONA by 369.9% in the first quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock valued at $4,102,000 after buying an additional 97,281 shares during the period. Intech Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the first quarter valued at $1,202,000. Finally, Duality Advisers LP purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at $1,166,000. Hedge funds and other institutional investors own 95.70% of the company’s shares.

DENTSPLY SIRONA Trading up 0.3%

Shares of XRAY opened at $24.73 on Thursday. The stock’s 50-day moving average is $25.63, and its two-hundred-day moving average is $29.41. The stock has a market cap of $5.13 billion, a PE ratio of -56.20, a P/E/G ratio of 1.16 and a beta of 1.01. DENTSPLY SIRONA Inc. has a 12-month low of $23.58 and a 12-month high of $38.36. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33, and a quick ratio of 0.87.

Want more great investment ideas?

DENTSPLY SIRONA (NASDAQ:XRAY – Get Your Free Report ) last issued its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The company’s revenue for the quarter was down 4.3% compared to the same quarter last year. In the same quarter last year, the firm earned $0.51 EPS. Equities analysts estimate that DENTSPLY SIRONA Inc. will post 1.98 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be given a $0.16 dividend. This represents an annualized dividend of $0.64 and a dividend yield of 2.59%. The ex-dividend date is Friday, September 27. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -145.45%.

Insider buying and selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 3,577 shares of the business’s stock in a transaction that occurred on Friday, May 31st. The shares were purchased at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the acquisition, the director now owns 58,374 shares in the company, valued at approximately $1,631,553.30. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC’s website. Insiders own 0.52% of the company’s shares.

Changes in Analyst Ratings

A number of brokerages have recently commented on XRAY. Robert W. Baird decreased their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Evercore ISI cut their price target on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Stifel Nicolaus cut their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Finally, Piper Sandler reiterated a “neutral” rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company presently has an average rating of “Moderate Buy” and a consensus price target of $33.44, based on data from MarketBeat.com.

Get our latest research report on XRAY

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions and Wellspect Healthcare. The company offers dental equipment including imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines and porcelain furnaces; and CAD/CAM dental technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full cost-effective restoration of esthetic ceramic dentistry, as well as the cloud-based DS Core. platform.